RankAlpha logo
Back to Rankings

ZURA

Zura BioC
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
ZURA vs peer average
56/100
ZURA vs. peer average (C vs. C)
Grade spread
A 2 · C 2 · D 6 · F 1
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

XFOR is the first available peer comparator.

Immunology-focused small-cap biotech with event-driven re-rating around clinical execution and financing risk; closer strategic analogue than broad biotech comps.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerXFORX4
ZURA
Zura Bio
XFOR
X4
Grade
C
A
Momentum
73
13
Value
41
41
Sentiment
65
100
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Constructive

Grade position vs XFOR

ZURA / XFOR
Grade Position
In line
ZURA vs. peer average (C vs. C)
56/100
Momentum
73
ZURA
Value
41
ZURA
Sentiment
65
XFOR

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs ZURA
1
XFOR
XFOR
A
100/100
-2
2
TECX
TECX
C
60/100
Even
3
ACIU
ACIU
D
40/100
+1
4
CTNM
Contineum Therapeutics Inc Class A Common
D
40/100
+1
5
AQST
Aquestive Therapeutics Inc Common
D
40/100
+1
XFOR is the first peer returned for this comparison set.